Biotech Firm Hit With COVID-Related Derivative Suit Over Warrant Revisions

(October 9, 2020, 1:20 PM EDT) -- SAN FRANCISCO — An investor sued a biotechnology company’s board of directors and a hedge fund in California federal court on Sept. 17, alleging that the defendants breached their fiduciary duty...
To view the full article, register now.